المؤلفون: Kettle, JG, Bagal, SK, Barratt, D, Bodnarchuk, MS, Boyd, S, Braybrooke, E, Breed, J, Cassar, DJ, Cosulich, S, Davies, M, Davies, NL, Deng, C, Eatherton, A, Evans, L, Feron, LJ, Fillery, S, Gleave, ES, Goldberg, FW, Gonzalez, MAC, Guerot, C, Haider, A, Harlfinger, S, Howells, R, Jackson, A, Johnstrom, P, Kemmitt, PD, Koers, A, Kondrashov, M, Lamont, GM, Lamont, S, Lewis, HJ, Liu, LB, Mylrea, M, Nash, S, Niedbala, MJ, Peter, A, Phillips, C, Pike, K, Raubo, P, Robb, GR, Ross, S, Sanders, MG, Schou, M, Simpson, I, Steward, O

المصدر: Journal of medicinal chemistry. 66(13):9147-9160

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:153054564

المؤلفون: Britten, TK, Kemmitt, PD, Halcovitch, NR, Coote, SC

مصطلحات الفهرس: Article, PeerReviewed

URL: https://e-space.mmu.ac.uk/625606/1/Coote%20Dihydropyridazines%20Revised.pdf
https://e-space.mmu.ac.uk/625606/
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1690825
https://e-space.mmu.ac.uk/625606
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1690825
10.1055/s-0039-1690825

المؤلفون: Britten, TK, Akien, GR, Kemmitt, PD, Halcovitch, NR, Coote, SC

مصطلحات الفهرس: Article, PeerReviewed

URL: https://e-space.mmu.ac.uk/625607/3/COOTE%20JOC%20Dihydropyridazines.pdf
https://e-space.mmu.ac.uk/625607/
https://www.sciencedirect.com/science/article/pii/S0040403919304150
https://e-space.mmu.ac.uk/625607
https://www.sciencedirect.com/science/article/pii/S0040403919304150
10.1016/j.tetlet.2019.04.054

المؤلفون: Smith JM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Barlaam B; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Beattie D; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Bradshaw L; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Chan HM; Research and Early Development, Oncology R&D, AstraZeneca, Waltham 02451, United States., Chiarparin E; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Collingwood O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Cooke SL; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Cronin A; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Cumming I; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Dean E; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Debreczeni JÉ; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Del Barco Barrantes I; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Diene C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Gianni D; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Guerot C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Guo X; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Guven S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Hayhow TG; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Hong T; Research and Early Development, Oncology R&D, AstraZeneca, Waltham 02451, United States., Kemmitt PD; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lamont GM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lamont S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lynch JT; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., McWilliams L; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Moore S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Raubo P; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Robb GR; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Robinson J; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Scott JS; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Srinivasan B; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Steward O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Stubbs CJ; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Syson K; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Tan L; Pharmaron Beijing Company, Ltd., Beijing 100176, P. R. China., Turner O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Underwood E; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Urosevic J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Vazquez-Chantada M; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Whittaker AL; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Wilson DM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Winter-Holt JJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom.

المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Aug 22; Vol. 67 (16), pp. 13604-13638. Date of Electronic Publication: 2024 Jul 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Protein-Arginine N-Methyltransferases*/antagonists & inhibitors , Protein-Arginine N-Methyltransferases*/metabolism , Enzyme Inhibitors*/pharmacology , Enzyme Inhibitors*/chemistry , Enzyme Inhibitors*/chemical synthesis, Humans ; Animals ; Structure-Activity Relationship ; Mice ; Drug Discovery ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/chemical synthesis

المؤلفون: Hong F; Department of Chemistry, University of Liverpool, Liverpool, UK., Aldhous TP; Department of Chemistry, University of Liverpool, Liverpool, UK.; School of Chemistry, University of Bristol, Bristol, UK., Kemmitt PD; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Bower JF; Department of Chemistry, University of Liverpool, Liverpool, UK. john.bower@liverpool.ac.uk.

المصدر: Nature chemistry [Nat Chem] 2024 Jul; Vol. 16 (7), pp. 1125-1132. Date of Electronic Publication: 2024 Apr 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101499734 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-4349 (Electronic) Linking ISSN: 17554330 NLM ISO Abbreviation: Nat Chem Subsets: MEDLINE

مواضيع طبية MeSH: Amino Acids*/chemistry , Iridium*/chemistry , Alkenes*/chemistry, Stereoisomerism ; Catalysis ; Glycine/chemistry ; Molecular Structure

المؤلفون: Cooper P; School of Chemistry, University of Bristol Bristol BS8 1TS UK., Dalling AG; School of Chemistry, University of Bristol Bristol BS8 1TS UK., Farrar EHE; Department of Chemistry, University of Bath Bath BA2 7AY UK M.N.Grayson@bath.ac.uk., Aldhous TP; School of Chemistry, University of Bristol Bristol BS8 1TS UK.; Department of Chemistry, University of Liverpool Crown Street Liverpool L69 7ZD UK john.bower@liverpool.ac.uk., Grélaud S; School of Chemistry, University of Bristol Bristol BS8 1TS UK., Lester E; School of Chemistry, University of Bristol Bristol BS8 1TS UK., Feron LJ; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca Cambridge UK., Kemmitt PD; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca Cambridge UK., Grayson MN; Department of Chemistry, University of Bath Bath BA2 7AY UK M.N.Grayson@bath.ac.uk., Bower JF; Department of Chemistry, University of Liverpool Crown Street Liverpool L69 7ZD UK john.bower@liverpool.ac.uk.

المصدر: Chemical science [Chem Sci] 2022 Sep 13; Vol. 13 (37), pp. 11183-11189. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101545951 Publication Model: eCollection Cited Medium: Print ISSN: 2041-6520 (Print) Linking ISSN: 20416520 NLM ISO Abbreviation: Chem Sci Subsets: PubMed not MEDLINE

المؤلفون: Khan Tareque R; Chemistry Deparment, University of Sussex, Falmer, East Sussex, BN1 9QJ, UK., Hassell-Hart S; Chemistry Deparment, University of Sussex, Falmer, East Sussex, BN1 9QJ, UK., Krojer T; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Bradley A; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Velupillai S; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Talon R; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Fairhead M; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Day IJ; Chemistry Deparment, University of Sussex, Falmer, East Sussex, BN1 9QJ, UK., Bala K; Chemistry Deparment, University of Sussex, Falmer, East Sussex, BN1 9QJ, UK., Felix R; Bio-Techne (Tocris Bioscience), The Watkins Building, Atlantic Road Avonmouth, Bristol, BS11 9QD, UK., Kemmitt PD; Medicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, CB10 1XL, UK., Brennan P; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK., von Delft F; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Diamond Light Source (DLS), Harwell Science and Innovation Campus, Didcot, Oxford, OX11 0DE, UK.; Department of Biochemistry, University of Johannesburg, Johannesburg, Auckland Park, 2006, South Africa., Díaz Sáez L; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK., Huber K; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK., Spencer J; Chemistry Deparment, University of Sussex, Falmer, East Sussex, BN1 9QJ, UK.

المصدر: ChemMedChem [ChemMedChem] 2020 Dec 15; Vol. 15 (24), pp. 2513-2520. Date of Electronic Publication: 2020 Sep 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE

مواضيع طبية MeSH: Benzene Derivatives/*chemical synthesis , Enzyme Inhibitors/*chemical synthesis , Small Molecule Libraries/*chemical synthesis, Benzene Derivatives/metabolism ; Catalysis ; Chemistry Techniques, Synthetic/methods ; Coordination Complexes/chemistry ; Crystallography, X-Ray ; Drug Design ; Enzyme Inhibitors/metabolism ; Feasibility Studies ; Humans ; Palladium/chemistry ; Proof of Concept Study ; Protein Binding ; Pyridines/chemical synthesis ; Pyridines/metabolism ; Pyrophosphatases/metabolism ; Pyrrolidinones/chemical synthesis ; Pyrrolidinones/metabolism ; Small Molecule Libraries/metabolism ; Nudix Hydrolases

المؤلفون: Britten TK; Department of Chemistry , Lancaster University , Bailrigg, Lancaster , LA1 4YB , U.K., Kemmitt PD; Medicinal Chemistry, Research and Early Development, Oncology R & D , AstraZeneca , Cambridge , CB10 1XL , U.K., Halcovitch NR; Department of Chemistry , Lancaster University , Bailrigg, Lancaster , LA1 4YB , U.K., Coote SC; Department of Chemistry , Lancaster University , Bailrigg, Lancaster , LA1 4YB , U.K.

المصدر: Organic letters [Org Lett] 2019 Nov 15; Vol. 21 (22), pp. 9232-9235. Date of Electronic Publication: 2019 Nov 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 100890393 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-7052 (Electronic) Linking ISSN: 15237052 NLM ISO Abbreviation: Org Lett Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: McCoull W; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Cheung T; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Anderson E; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Barton P; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Burgess J; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Byth K; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Cao Q; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Castaldi MP; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Chen H; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Chiarparin E; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Carbajo RJ; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Code E; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Cowan S; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Davey PR; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Ferguson AD; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Fillery S; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Fuller NO; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Gao N; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Hargreaves D; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Howard MR; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Hu J; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Kawatkar A; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Kemmitt PD; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Leo E; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Molina DM; Pelago Bioscience AB , Banvaktsvägen 20 , 17148 Solna , Sweden., O'Connell N; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Petteruti P; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Rasmusson T; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Raubo P; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Rawlins PB; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Ricchiuto P; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Robb GR; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Schenone M; Broad Institute of Harvard and MIT , 7 Cambridge Center , Cambridge , Massachusetts 02142 , United States., Waring MJ; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K., Zinda M; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Fawell S; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , Gatehouse Park , Waltham , Massachusetts 02451 , United States., Wilson DM; Oncology and Discovery Sciences, IMED Biotech Unit , AstraZeneca , 310 Cambridge Science Park, Milton Road , Cambridge CB4 0WG , U.K.

المصدر: ACS chemical biology [ACS Chem Biol] 2018 Nov 16; Vol. 13 (11), pp. 3131-3141. Date of Electronic Publication: 2018 Oct 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Proto-Oncogene Proteins c-bcl-6/*antagonists & inhibitors , Quinolones/*pharmacology , Thalidomide/*analogs & derivatives , Thalidomide/*pharmacology, Adaptor Proteins, Signal Transducing ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/metabolism ; Cell Line, Tumor ; HEK293 Cells ; Humans ; Ligands ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Peptide Hydrolases/metabolism ; Protein Binding ; Proteolysis ; Proto-Oncogene Proteins c-bcl-6/chemistry ; Proto-Oncogene Proteins c-bcl-6/metabolism ; Quinolones/chemical synthesis ; Quinolones/metabolism ; Thalidomide/chemical synthesis ; Thalidomide/metabolism ; Ubiquitin-Protein Ligases/metabolism

المؤلفون: Khan R; Department of Chemistry School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Boonseng S; Department of Chemistry School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Kemmitt PD; Oncology AstraZeneca 310 Cambridge Science Park Milton Road Cambridge CB4 0WG UK., Felix R; Tocris Bioscience, the Watkins Building Atlantic Road, Avonmouth Bristol BS11 9QD UK., Coles SJ; UK National Crystallography Service School of Chemistry University of Southampton Highfield Southampton SO17 1BJ U.K., Tizzard GJ; UK National Crystallography Service School of Chemistry University of Southampton Highfield Southampton SO17 1BJ U.K., Williams G; Sussex Drug Discovery Centre School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Simmonds O; Sussex Drug Discovery Centre School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Harvey JL; Sussex Drug Discovery Centre School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Atack J; Sussex Drug Discovery Centre School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Cox H; Department of Chemistry School of Life Sciences University of Sussex Falmer BN1 9QJ UK., Spencer J; Department of Chemistry School of Life Sciences University of Sussex Falmer BN1 9QJ UK.

المصدر: Advanced synthesis & catalysis [Adv Synth Catal] 2017 Sep 18; Vol. 359 (18), pp. 3261-3269. Date of Electronic Publication: 2017 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Germany NLM ID: 101095751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1615-4150 (Print) Linking ISSN: 16154150 NLM ISO Abbreviation: Adv Synth Catal Subsets: PubMed not MEDLINE